Screener
Halozyme Therapeutics HALO Common Stock Par Value Per Share
Common Stock Par Value Per Share at other companies
Other financials
Where this comes from
Reported directly by Halozyme Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.
The source filing: Halozyme Therapeutics’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:11 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001159036-26-000104
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Commitments and contingencies (Note 11) | ||
| Stockholders’ equity | ||
| Preferred stock - $0.001 par value; 20,000 shares authorized; no shares issued and outstanding | — | — |
| Common stock - $0.001 par value; 300,000 shares authorized; 114,042 and 117,782 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | 114 | 118 |
| Additional paid-in capital | — | 12,002 |
| Accumulated other comprehensive loss | (7,830) | (18,092) |
| Retained earnings | 151,259 | 54,786 |
| Total stockholders’ equity | 143,543 | 48,814 |
Item 1. Financial Statements
FAQ
- What is Halozyme Therapeutics's common stock par value per share?
- Halozyme Therapeutics (HALO) reported common stock par value per share of $0.00 in Q2 2026.
- How has Halozyme Therapeutics's common stock par value per share changed year-over-year?
- Halozyme Therapeutics's common stock par value per share decreased by 0.0% year-over-year, from $0.00 to $0.00.
- What is the long-term trend for Halozyme Therapeutics's common stock par value per share?
- Over 5 years (2020 to 2025), Halozyme Therapeutics's common stock par value per share has grown at a 0.0% compound annual growth rate (CAGR), from $0.00 to $0.00.
- What does common stock par value per share mean?
- The par value of common stock is the arbitrary legal value assigned to each share of common stock at the time of issuance. It is a legacy accounting requirement that has little impact on the actual market value or trading price of the shares.
Ask your AI about Halozyme Therapeutics's common stock par value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude